11 Best Pharma Stocks To Buy Now - Insider Monkey
In this article, we discuss the 12 best pharma stocks to buy now.
Source: insidermonkey.com
📰 Assembly Bio News
Page 2 - Assembly Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Assembly Bio. Real-time updates on events, politics, business and more.
Nano-Cap Stock Momentum Watchlist (SING, MGRX, ICU, ASMB)
In the world of investing, spotting stocks that are gaining momentum is a well-worn strategy for those seeking potential profits. These stocks, exhibiting remarkable movements, often sustain their...
United States State Of California Mark Mckelvie Capitalgainsreport Razorpitch Drug Administration Singlepoint Inc
Source: marketscreener.com
Assembly Biosciences : 737.6 KB -October 17, 2023 at 09:13 am EDT
Assembly Bio Webcast Gilead Sciences Development Partnership for Next-Generation Antiviral Therapeutics October 17,...
Exchange Commission Assembly Bio Securities Exchange Risk Factors In Assembly Bio Securities Act Securities Exchange Act
Source: marketscreener.com
Hepatitis-Focused Assembly Biosciences Stock Trading Over 100% Higher: Here's Why - Assembly Biosciences (NASDAQ:ASMB)
Gilead Sciences Inc (NASDAQ: GILD) and Assembly Biosciences Inc (NASDAQ: ASMB) have entered into a 12-year partnership.
Source: benzinga.com
Gilead Sciences, Inc. and Assembly Biosciences, Inc. Establish Partnership to Develop Next-Generation Therapeutics for Serious Viral Diseases
Gilead Sciences, Inc. and Assembly Biosciences, Inc. announced that the companies have entered into a 12-year partnership to advance the research and development of novel antiviral therapies, with an...
United States Assembly Bio Assembly Biosciences Inc Gilead Sciences Inc Terms Of The Partnership Gilead Sciences
Source: marketscreener.com
Gilead inks $100M partnership with Assembly Bio for antivirals
Gilead will pay $100 million upfront for the deal, which will involve developing therapies for herpes simplex virus and hepatitis B virus.
Source: mmm-online.com
Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV at the 2023 International HBV Meeting
-- Two oral presentations and one poster will feature new data from the Company’s hepatitis B/hepatitis D entry inhibitor, capsid assembly modulator ABI-4334, and interferon-alpha receptor agonist...
Marcp Windisch William Delaney Shannon Ryan Nuruddin Unchwaniwala Assembly Biosciences Inc Entry Inhibitor Program
Source: marketscreener.com
Assembly Biosciences Presents New Data Highlighting Herpes Simplex Virus Development Candidate ABI-5366 at the 47th Annual International Herpesvirus Workshop
-- First presentation of preclinical data describing the activity, pharmacokinetics and safety profile of ABI-5366, supporting planned clinical entry in 1H 2024 -- SOUTH SAN FRANCISCO, Calif.,...
United States William Delaney Shannon Ryan Risk Factors In Assembly Bio Alliance Management International Herpesvirus Workshop
Source: marketscreener.com
Assembly Biosciences Presents New Data Highlighting Entry Inhibitor and Core Inhibitor Programs at EASL's International Liver Congress™ 2023
SOUTH SAN FRANCISCO, Calif., June 21, 2023 -- Assembly Biosciences, Inc. , a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today... | June 21, 2023
William Delaney Shannon Ryan Exchange Commission Sam Brown Inc Corporate Affairs International Liver Congress
Source: marketscreener.com